8.32

5.72% 0.45

Pre-market: 7.51 -0.81 -9.74%

Sera Prognostics Inc (SERA)

Overview News Price History Financials Discussions Forecast

Sera Prognostics Inc stock is traded at $8.32, with a volume of 111.18K. It is up +5.72% in the last 24 hours and up +8.47% over the past month. Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Previous Close:

$7.87

Open:

$7.95

24h Volume:

111.18K

Relative Volume:

1.25

Market Cap:

$280.99M

Revenue:

$306.00K

Net Income/Loss:

$-36.24M

P/E Ratio:

-7.1724

EPS:

-1.16

Net Cash Flow:

$-27.32M

1W Performance:

-0.12%

1M Performance:

+8.47%

6M Performance:

+57.28%

1Y Performance:

+60.00%

1-Day Range:

$7.95

$8.73

1-Week Range:

$7.555

$8.73

52-Week Range:

$4.90

$12.36

Sera Prognostics Inc Stock (SERA) Company Profile

Name

Sera Prognostics Inc

Sector

Healthcare (1233)

Industry

Medical Devices (1)

Phone

(801) 990-0520

Address

2749 E. PARLEYS WAY, SALT LAKE CITY

Employee

Twitter

Next Earnings Date

2022-11-09T21:00:00.000Z

Latest SEC Filings

SERA's Discussions on Twitter

Compare SERA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SERA Sera Prognostics Inc	8.32	280.99M	306.00K	-36.24M	-27.32M	-1.16
ABT Abbott Laboratories	114.25	198.16B	41.22B	5.77B	6.49B	3.29
BSX Boston Scientific Corp	95.95	141.41B	15.91B	1.79B	1.89B	1.21
SYK Stryker Corp	364.10	138.80B	21.97B	3.59B	3.21B	9.33
MDT Medtronic Plc	82.68	106.02B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.15	43.73B	6.60B	4.16B	490.10M	6.93

Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-30-22	Downgrade	Citigroup	Buy → Neutral
Nov-19-21	Initiated	Oppenheimer	Outperform
Oct-15-21	Resumed	Cowen	Outperform

Sera Prognostics Inc Stock (SERA) Latest News

Jan 09, 2025

Where are the Opportunities in (SERA) - Stock Traders Daily

Jan 09, 2025

Jan 08, 2025

Sera Prognostics announces PRIME study results to be discussed - Investing.com

Jan 08, 2025

Jan 07, 2025

Sera prognostics director sells shares worth $769 By Investing.com - Investing.com Australia

Jan 07, 2025

Sera prognostics director sells shares worth $769 - Investing.com

Jan 07, 2025

Jan 06, 2025

Sera Prognostics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 06, 2025

Geode Capital Management LLC Acquires 47,969 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World

Jan 06, 2025

Jan 05, 2025

Barclays PLC Buys 30,093 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World

Jan 05, 2025

Dec 31, 2024

State Street Corp Buys 34,479 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World

Dec 31, 2024

Dec 29, 2024

(SERA) Investment Report - Stock Traders Daily

Dec 29, 2024

Dec 19, 2024

With 40% stake, Sera Prognostics, Inc. (NASDAQ:SERA) seems to have captured institutional investors' interest - Yahoo Finance

Dec 19, 2024

Dec 18, 2024

Trend Tracker for (SERA) - Stock Traders Daily

Dec 18, 2024

Dec 09, 2024

Sera Prognostics director Mirza Mansoor Raza sells $662 in stock By Investing.com - Investing.com South Africa

Dec 09, 2024

Sera Prognostics director Mirza Mansoor Raza sells $662 in stock - Investing.com

Dec 09, 2024

Dec 08, 2024

(SERA) Technical Pivots with Risk Controls - Stock Traders Daily

Dec 08, 2024

Dec 07, 2024

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024 - The Eastern Progress Online

Dec 07, 2024

Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference - The Eastern Progress Online

Dec 07, 2024

Dec 04, 2024

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting | State News | hjnews.com - The Herald Journal

Dec 04, 2024

Sera Prognostics' Breakthrough PreTRM Test Study Selected for Elite Presentation at Major Pregnancy Conference - StockTitan

Dec 04, 2024

Dec 01, 2024

Sera Prognostics, Inc. (NASDAQ:SERA) Shares Bought by Quest Partners LLC - Defense World

Dec 01, 2024

Nov 18, 2024

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health and Services Forum - Marketscreener.com

Nov 18, 2024

Nov 16, 2024

How To Trade (SERA) - Stock Traders Daily

Nov 16, 2024

Nov 15, 2024

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Longview News-Journal

Nov 15, 2024

Have Sera Prognostics Insiders Been Selling Stock? - Simply Wall St

Nov 15, 2024

Nov 13, 2024

Sera Prognostics director sells $695 in stock By Investing.com - Investing.com South Africa

Nov 13, 2024

Sera Prognostics chief data officer sells $29,850 in stock By Investing.com - Investing.com Nigeria

Nov 13, 2024

Sera Prognostics chief data officer sells $29,850 in stock - Investing.com India

Nov 13, 2024

Nov 12, 2024

Sera Prognostics director sells $695 in stock - Investing.com

Nov 12, 2024

Sera Prognostics CEO Lindgardt Zhenya sells shares worth $88,389 - Investing.com

Nov 12, 2024

Nov 08, 2024

Sera Prognostics, Inc. (NASDAQ:SERA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024